Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Curcumin × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 17 Genitourinary 10 Breast 9 Gynecologic 6 Plasma cell 5 Thoracic 3 Lymphoid 3 Other hematologic neoplasm 2 Other 1 Myeloid 1 Head & Neck 1 Dermatologic 1 CNS 1

Conditions

Head and Neck Neoplasms 1

Interventions

Cisplatin 504 pembrolizumab 267 Radiotherapy 263 Cetuximab 223 Docetaxel 185 Radiotherapy, Intensity-Modulated 178 Carboplatin 163 Fluorouracil 161 Paclitaxel 131 Nivolumab 111 Gemcitabine 106 Radiation 74 Magnetic Resonance Spectroscopy 73 toripalimab 66 Drug Therapy 66 Capecitabine 62 durvalumab 52 Surgical Procedures, Operative 51 Biopsy 43 Cyclophosphamide 41 camrelizumab 39 Bevacizumab 37 Standard of Care 36 Erlotinib Hydrochloride 36 Chemoradiotherapy 36 tislelizumab 35 Specimen Handling 35 Radiosurgery 34 130-nm albumin-bound paclitaxel 34 atezolizumab 33

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04208334 2023-03-28

CurChexia

Phramongkutklao College of Medicine and Hospital

Phase 2 Completed

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡